TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs

Overview of attention for article published in Journal of Clinical Investigation, September 2005

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

patent: 27 patents
wikipedia: 6 Wikipedia pages

guideline: 1 clinical guideline source

Readers on

mendeley: 157 Mendeley
connotea: 1 Connotea

So far, Altmetric has seen 27 patents that reference this research output.

NR4A-deficient cells expressing c-Jun and uses thereof

Grant US-12679879-B2

United States of America

14 Jul 2026

Genetically modified bacteria stably expressing IL-10 and insulin

Grant US-12359210-B2

United States of America

15 Jul 2025

METHODS FOR TREATING TYPE 1 DIABETES

Application WO-2025024848-A1

World Intellectual Property Organisation (WIPO)

30 Jan 2025

METHODS FOR REDUCING EXOGENOUS INSULIN USE

Application WO-2024206739-A1

World Intellectual Property Organisation (WIPO)

03 Oct 2024

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 23 additional patents.